Comparison of a Novel Tazarotene 0.045% Lotion to Tazarotene 0.1% Cream: Patient-Reported Outcomes from a Phase 2 Clinical Trial

Main Article Content

Z Draelos
F Cook-Bolden
L Green
E Guenin
G Martin
R Pillai

Keywords

Tazarotene, Acne

Abstract

Abstract not available.

References

1. Zaenglein AL, et al. J Am Acad Dermatol. 2016;74(5):945-973.
2. Tanghetti EA, et al. J Drugs Dermatol. 2019;18(6):542-548.
3. Acne-specific Quality of Life Questionnaire (Acne-QoL) Manual & Interpretation Guide. January 2003. http://www.anzctr.org.au/Steps11and12/376709-(Uploaded-11- 01-2019-20-05-40)-Study-related%20document.pdf